Yingli Pharma announce promising topline results of a Phase II registration study for treatment of …,

Linperlisib provides significant clinical improvement in the treatment for patients with relapsed and/or refractory follicular lymphomaLinperlisib has a …, Linperlisib provides significant clinical improvement in the treatment for patients with relapsed and/or refractory follicular lymphomaLinperlisib has a …, Read More

Scroll to Top